ALKEM - IntraDay Trade Analysis with Live Signals

Last Updated Time : 20 Dec 25, 07:02 am

IntraDay Trade Rating: 3.7

📊 Analysis: ALKEM trades at ₹5,556, slightly below its DMA 50 (₹5,592) but above DMA 200 (₹5,349), showing mixed technical signals. RSI at 39.6 indicates oversold conditions, which may trigger a rebound, though MACD (-8.99) confirms bearish momentum. Volume (35K vs 47K avg) is slightly weak, limiting intraday strength. Fundamentals remain solid with strong ROE (19.9%) and quarterly profit growth (+12.8%). Suitable for cautious intraday trades with disciplined risk management.

• 💹 Optimal Buy Price: ₹5,540–5,560 (near current support zone)
• 🎯 Profit-Taking Levels: ₹5,600 (first resistance), ₹5,640 (next resistance)
• 🛡️ Stop-Loss: Below ₹5,520 (to protect against breakdown)
• ⏱️ Exit if Holding: Exit intraday if price fails to sustain above ₹5,540 or if RSI slips below 38 with MACD staying negative despite institutional support.

Positive

• ✅ Strong ROE 19.9% and ROCE 19.5% reflect efficient capital use.
• ✅ Quarterly profit growth (+12.8%) shows operational strength.
• ✅ Low debt-to-equity 0.06 ensures financial stability.
• ✅ FII and DII holdings increased (+0.36% and +0.13%), showing institutional confidence.

Limitation

• ⚠️ Price below DMA 50, reflecting short-term weakness.
• ⚠️ RSI near oversold (39.6), limiting momentum strength.
• ⚠️ MACD negative (-8.99), confirming bearish sentiment.
• ⚠️ PEG ratio 2.13 suggests growth is expensive relative to earnings.

Company Negative News

• ❌ Weak technicals with RSI oversold and MACD bearish.
• ❌ Volume below average, limiting intraday strength.

Company Positive News

• 🌟 Profit growth from ₹610 Cr. to ₹724 Cr. in latest quarter.
• 🌟 Dividend yield 0.82% supports investor sentiment.
• 🌟 Institutional support with both FII and DII increasing stakes.

Industry

• 🏗️ Industry PE at 30.6 vs ALKEM PE 29.7 shows fair valuation.
• 🏗️ Pharma sector remains resilient with defensive demand and strong fundamentals.

Conclusion

📌 ALKEM is a moderate intraday candidate with strong fundamentals but weak technicals. Traders may attempt scalps near ₹5,540–5,560 with profit exits around ₹5,600–5,640, while maintaining a disciplined stop-loss below ₹5,520.

Would you like me to extend this into a pharma sector basket overlay with peer benchmarking so you can compare ALKEM against other large-cap pharma stocks for intraday rotation opportunities?